Global Microsurgery Market is valued at USD 2206.9 Million in 2022 and expected to reach USD 3214.5 Million by 2029 with a CAGR of 5.52% over the forecast period.
Global Microsurgery Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, and 2023-2029- Increasing prevalence of chronic diseases, rising geriatric population and growing demand from minimally invasive surgeries are some of the major factors driving the growth of the Global Microsurgery Market.
Microsurgery is a surgical technique that uses specialized instruments and microscopes to perform intricate procedures on small, delicate structures in the body, such as blood vessels, nerves, and lymphatic vessels. The goal of microsurgery is to repair or reconstruct damaged tissue in a way that preserves function and minimizes scarring. Microsurgery is typically performed on an outpatient basis under general anaesthesia. The surgeon makes a small incision in the skin and uses a microscope and specialized instruments to carefully manipulate the tissue. The surgeon may use magnification up to 40 times to perform the procedure with extreme precision. Microsurgery requires a high level of skill and training, and it is typically performed by specially trained surgeons who have completed additional fellowship training in microsurgery. The use of microsurgery has revolutionized the field of surgery and has allowed for more precise and effective treatments for a variety of conditions. In 1960, Dr. Jacobson and Dr. Suarez successfully performed the first microvascular anastomosis, or the joining of two small blood vessels using a microscope.
The Covid-19 pandemic has had a mixed impact on the global microsurgery market. On one hand, there has been a significant reduction in elective surgeries due to the prioritization of Covid-19 patients, resulting in decreased demand for microsurgery procedures. On the other hand, the need for emergency and urgent surgeries has increased, leading to a rise in the adoption of microsurgery techniques. Additionally, the growing trend of telemedicine and remote consultation has opened up new opportunities for the market, as surgeons are able to use advanced technology to remotely guide procedures. Despite the short-term challenges posed by the pandemic, the global microsurgery market is expected to recover and continue to grow in the long term, driven by factors such as the increasing prevalence of chronic diseases, advancements in technology, and growing demand for minimally invasive surgical procedures.
The global microsurgery market is segmented based on equipment, procedure, application, end-user, and region & country level. Based on equipment, the global microsurgery market is segmented into micro forceps, micro sutures, operating microscopes, microsurgery needle holder, and others. Based on procedure, the market is segmented into transplantation, free tissue transfer, suture and grafting, and others. Based on application, the global microsurgery market is segmented into neurology, orthopedic, gynecological & urological microsurgery, plastic & reconstructive, ophthalmic, oncology, and others. Based on end-user, the market is segmented into ambulatory surgical centers, hospitals & clinics, academics and research institutes, and others.
The regions covered in the global microsurgery market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global microsurgery is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.
Some major key players for the global microsurgery market report cover prominent players like -
One of the major factors driving the growth of the global microsurgery market is the increasing prevalence of chronic diseases is one of the major factors driving the market growth. For example; according to International Diabetic Federation (IDF), in 2021, there are about 537 million adults (20-79 years) are living with diabetes and number is projected to increase about 643 million by 2030 and 783 million by 2045. In addition, rising geriatric population is also supplementing the market growth. The aging population is more prone to the chronic diseases such as cancer, cardiovascular disease, and diabetes. For example; according to WHO; By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from one billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). Microsurgery is used to treat these conditions, offering targeted and effective treatments that minimize damage to healthy tissue. Therefore, increasing prevalence of chronic diseases drives global microsurgery market.
Moreover, the growing demand for minimally invasive surgeries is also boosting the growth of the global microsurgery market. Patients are increasingly preferring minimally invasive surgical techniques due to their lower risk of complications, faster recovery times, and reduced hospital stays. Microsurgery is an ideal technique for many minimally invasive surgical procedures.
However, a shortage of skilled healthcare professionals & physicians as well as lacking perioperative care may hamper the growth of the global microsurgery market. Despite that, the development of advanced surgical instruments and imaging technologies such as high-resolution cameras and 3D printing may provide more opportunities for the further growth of the market.
North America is expected to dominate the global microsurgery market within the forecast period due to the rising prevalence of heart diseases, the growing geriatric population, and the technological advancements in this field in this region. For instance; as per the Centers for Disease Control and Prevention (CDC); there are about 697,000 people in the United States died from heart disease in 2020. Also, the growing geriatric population drives the market in the region. For example; as per the U.S. Census Bureau, in 2020, more than 56 million adults ages 65 and older live in the US, representing around 16.9% of the country's populace.
Asia Pacific is the fastest-growing region in the global microsurgery market because of skilled workforce and growing healthcare expenditure in this region. For instance; For example, in 2018, the Chinese government invested over $125 billion in healthcare infrastructure, leading to a surge in demand for advanced medical technologies such as microsurgery. In addition, Asia Pacific region is home to a skilled and highly trained workforce, including microsurgeons who are trained to perform complex surgical procedures using microsurgery techniques. For example; the Chinese Society for Surgery of the Hand has over 6,000 members who specialize in microsurgery techniques for hand and wrist surgeries.
Medical Microinstruments Launched New NanoWrist Instruments for Surgical Robot
On September 7th, 2022; Medical Microinstruments announced that it launched its new supermicro NanoWrist instruments for its Symani surgical robot. Italy-based Clinical Microinstruments planned the Nanowrist instruments to address the difficulties of microsurgery. Surgeons in Europe newly utilized the new supermicro needle holder and dilator in clinical procedures with successful results.
Microsure Raises € 2.7 Million Under New Leadership for the Further Development and Clinical Roll-Out of the MUSA Microsurgery Robot Assistant
On April 29th, 2021; Microsure announced the closing of a funding round of € 2.7 million, as an expansion of the 2020 Series B round. The funds will be utilized to proceed the initial clinical carry out of MUSA, the primary CE- marked and supported micro-surgical robot associate. This round was driven by Invest-NL, the other half of the financing came from the current investors BOM Brabant Ventures and funding capital investor Innovation Industries, as well as from private investor Ten Cate Investeringsmaatschappij (TCIM). Microsure's MUSA is the world's most memorable clinically accessible CE- certified surgical robot for microsurgery. It is created by a group of engineers and specialists, making a solution that is viable with current working methods, instruments, and other OR- equipment.
|Historical data||2016 - 2021|
|Forecast Period||2022 - 2029|
|Market Size in 2022:||USD 2206.9 Million|
|Base year considered||2021|
|Forecast Period CAGR %:||
|Market Size Expected in 2029:||USD 3214.5 Million|
|Tables, Charts & Figures:||175|
|Companies||Accurate Surgical & Scientific Instruments Corporation, Danaher, Haag-Streit Group, Synovis Micro Companies Alliance, Inc, Medtronic, Novartis AG, Olympus Corporation, AROSurgical Instruments, Baxter, Halma PLC, Accurate Surgical & Scientific Instruments Corporation, Aesculap, Inc., Scanlan International., Peter LAZIC GmbH, Surtex Instruments Limited, and others|
|Segments Covered||By Equipment, By Application, By Procedure, By End-User|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®